Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04260724 Not yet recruiting - Clinical trials for Mild to Moderate Alzheimer Disease

Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease

Start date: February 7, 2020
Phase: N/A
Study type: Interventional

The investigators will compare cognitition, mood (depression), ADL, and brain structural and functional MRI before and after 4-week transcranial magnetic stimulation in patients with mild to moderate Alzheimer's disease. The investigators also compare the change of cognitition, mood (depression), ADL, and brain structural and functional MRI between TMS group and sham coil group.

NCT ID: NCT04260633 Not yet recruiting - Clinical trials for Dental Monitoring Accuracy

Optimizing Aligner Wear Time and Change Frequency

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This study aims to help improve individualization and optimization of clear aligner therapy through the use of new technologies in orthodontics. The study will compare 12-hour and 22-hour tray wear time and evaluate the adjunctive use of Vpro+. The study clinicians will use Dental Monitoring to monitor study participants throughout the trial and will use the Dental Monitoring system to instruct patients to continue or stay on their clear aligners. The outcome of the study will be the time it takes to complete 10 trays.

NCT ID: NCT04257942 Not yet recruiting - Clinical trials for Crystallization of Cholesterol in Atherosclerosis

Pathological Crystallization of Cholesterol in Atherosclerosis

Start date: May 1, 2020
Phase:
Study type: Observational [Patient Registry]

Endarterectomy of the carotid artery procedure will be performed at Sheba Medical center vascular surgery department, followed by fixation and histology. Tissues will then be transferred to Weizmann Institute of Science for observation implementing advanced electron microscopy techniques. Finally, joint evaluation of the results will be carried out, in relation to the patient clinical history.

NCT ID: NCT04255901 Not yet recruiting - Clinical trials for Sleep Initiation and Maintenance Disorders

Efficacy of Head-point Acupuncture on Insomnia

Start date: August 1, 2020
Phase:
Study type: Observational

The investigators will conduct a single-center case series study. A total of 40 participants with insomnia will be enrolled. The aim of the study is to assess the therapeutic effect of head-point acupuncture for the treatment of insomnia.

NCT ID: NCT04255355 Not yet recruiting - Clinical trials for Glenohumeral Internal Rotation Deficit

Comparing the Effects of Pelvic Alignment Versus Diaphragmatic Breathing on Shoulder Range of Motion

Start date: July 30, 2020
Phase: N/A
Study type: Interventional

The goal of this research study is to compare the effects of pelvic alignment versus diaphragmatic breathing on range of motion in the shoulder joint in both athletic and nonathletic population. The investigators plan to have approximately 45 participants to take part in this study. Subjects will be assigned into three groups. Group 1 will perform both pelvic alignment and diaphragmatic breathing exercises. This group will be used as the standard or control group. Group 2 will perform pelvic alignment exercise only; and Group 3 will perform diaphragmatic exercises only. The shoulder internal rotation range will be assessed in all three groups. Maximal expiratory rate will be measured in group 3 to assure improved diaphragmatic breathing in subjects. The shoulder internal rotation range in group 2 & 3 will be compared to the shoulder range of motion in the standard group.

NCT ID: NCT04255069 Not yet recruiting - Clinical trials for Nonalcoholic Steatohepatitis (NASH) With Fibrosis

A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Start date: June 30, 2020
Phase: Phase 2
Study type: Interventional

A double-blind placebo controlled randomized Phase 2 study to determine if JKB-122 compared with placebo resolves NASH on liver biopsy and improves fibrosis

NCT ID: NCT04253847 Not yet recruiting - Clinical trials for Radical Antegrade Modular Pancreatosplenectomy

RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma

Start date: February 15, 2020
Phase: N/A
Study type: Interventional

Two arms RCT is design, patients with pancreatic body or tail adenocarcinoma will be randomly assigned to the Radical Antegrade Modular Pancreaticosplenectomy (RAMPS) group or Standard Retrograde Pancreatosplenectomy (SRPS) group. The primary objective is to evaluate the effect of RAMPS on the overall survival of patients with resectable body and tail pancreatic ductal adenocarcinoma. And the secondary objective is to evaluate the disease-free survival, R0 resection rate, number of retrieved lymph nodes and perioperative outcomes like postoperative complication rate, severe complications, mortality and functional recovery time between the experimental group and control group.

NCT ID: NCT04253769 Not yet recruiting - Clinical trials for Hematologic Disease and Disorders

NHLBI Research Participant Recruitment Registry

Start date: February 14, 2020
Phase:
Study type: Observational

Background: The National Heart, Lung, and Blood Institute (NHLBI) conducts clinical trials that look at new ways to prevent, detect, or treat disease. It wants to create an NHLBI Recruitment Registry that lets people sign up to be contacted for NHLBI studies. It also wants to make sure that the data people share about themselves is safely stored. Researchers will be able to use this registry to prescreen people for clinical trials. Objective: To create and maintain an NHLBI research participant recruitment registry. This is an observational registry for collecting, storing, and providing access to data on people with a disease or condition of interest, or as a healthy volunteer to the NHLBI. Eligibility: People who contact the NIH to participate in an NHLBI IRB-approved study Design: Researchers will contact participants by telephone to obtain informed consent verbally. Participants will give the following data: - name - date of birth - phone number - address - email address - diagnosis (if applicable) - referring provider. Participants will share how they heard of the study. They may give their medical records. They may be asked if they were enrolled in an NHLBI study in the past. Participants will be asked if they would like to be contacted for other current or future studies. If they say no, they will not be contacted. But their data will stay in the database. They can also withdraw from the registry. If they do, their reason will be recorded in the database. The registry will be created and maintained by the Office of the Clinical Director at NHLBI.

NCT ID: NCT04252352 Not yet recruiting - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Treatment of Acne Scars With Fractional CO2 Laser Versus Radio-frequency Microneedling

Start date: February 2020
Phase: N/A
Study type: Interventional

The study is a prospective, randomized, controlled, intra-person split-face trial with blinded evaluations. The objective is to compare efficacy and adverse effects of ablative fractional CO2 laser resurfacing versus radio-frequency microneedling for treatment of atrophic acne scars in the facial area. Two comparable areas with acne scars on each side of the face are treated. One area will be treated with fractional CO2 laser and the other area with radio-frequency microneedling. Outcome measures will be assessed by blinded investigators and included subjects at baseline before treatment and at follow-up visits 2-4 days and 1 and 3 months post-treatment. On-site assessment and OCT will be performed at the time of the visits. OCT scans will be offered to the subjects and are optional. Clinical photos are used for documentation. 15 participants will be recruited. The participants will be recruited to enter the trial in the clinic by investigators at the Department of Dermatology, Bispebjerg Hospital, and must meet the inclusion criteria (at least 18 years of age, acne scars in the facial area, comparable atrophic acne scars on each side of the face, fitzpatrick skintype I-III) to be eligible to enter the study. No personal remuneration will be awarded the investigators. None of the collaborators have any personal economic interest in the study. Participants will not receive remuneration. All treatments are performed at the Department of Bispebjerg Hospital and patients are covered by the Hospital's patient insurance. The declaration of Helsinki will be respected as well as the standards of good clinical research. Respect for privacy as well as physically and mentally integrity of the participants will be maintained. The study will be performed in accordance with Danish Health care authorities.

NCT ID: NCT04252001 Not yet recruiting - Clinical trials for Growth Hormone Deficiency

Growing up With the Young Endocrine Support System (YESS!)

YESS
Start date: December 1, 2024
Phase: N/A
Study type: Interventional

Transition from paediatric to adult endocrinology is a challenge for adolescents, families and doctors. Up to 25% of young adults with chronic endocrine disorders are lost to follow-up ('drop-out') once the young adult moves out of paediatric care. Non-attendance and sub-optimal medical self-management can lead to serious and expensive medical complications. In a pilot study, adolescents suggested the use of e-technology to become more involved in the transition process. The investigators have designed and developed the YESS! game, a tool to help improve medical self-management in adolescents with chronic endocrine disorders. The hypothesis is that adolescents playing the YESS! game will show a larger increase in self-management score during the first year of transition and will have a lower drop-out rate at the adult endocrine outpatient clinic (OPC), compared to adolescents who do not play the game.